A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Inspire Md, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 26,176 shares of NSPR stock, worth $65,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,176
Holding current value
$65,440
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$2.19 - $2.7 $57,325 - $70,675
26,176 New
26,176 $59,000
Q4 2022

Feb 14, 2023

BUY
$0.81 - $1.44 $30,259 - $53,794
37,357 New
37,357 $32,000

Others Institutions Holding NSPR

About InspireMD, Inc.


  • Ticker NSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,323,200
  • Market Cap $20.8M
  • Description
  • InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applic...
More about NSPR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.